Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Y Kim

Showing results (161-170 of 168) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 168 results.
Alimentary Pharmacology & Therapeutics|November 10, 2011
Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patientsH G Park, M K Jung, J T Jung, et al.
BMC Geriatrics|November 3, 2021
Sarcopenia is associated with decreased gray matter volume in the parietal lobe: a longitudinal cohort studyJi Hee Yu, Regina E Y Kim, Jin-Man Jung, et al.
Frontiers in Neurology|September 19, 2022
Night blood pressure variability, brain atrophy, and cognitive declineJi Hee Yu, Regina E Y Kim, So Young Park, et al.
Scientific Reports|May 28, 2024
A multimodal machine learning model for predicting dementia conversion in Alzheimer's diseaseMin-Woo Lee, Hye Weon Kim, Yeong Sim Choe, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 25, 2025
Neuroimaging correlates and biomarker performance of a fully automated plasma p-tau217/Aβ42 ratio assay in a clinical cohort with Alzheimer's diseaseYoo Hyun Um, Paul Wynveen, Mark Holland, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|November 29, 2011
Prognostic factors for idiopathic pulmonary fibrosis: clinical, physiologic, pathologic, and molecular aspectsS H Lee, H S Shim, S H Cho, et al.
Cell Death & Disease|March 15, 2014
Stronger proteasomal inhibition and higher CHOP induction are responsible for more effective induction of paraptosis by dimethoxycurcumin than curcuminM J Yoon, Y J Kang, J A Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2017
Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinomaH R Kim, H N Kang, H S Shim, et al.
Pageof 17

Showing results (161-170 of 168) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
Alimentary Pharmacology & Therapeutics|November 10, 2011
Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patientsH G Park, M K Jung, J T Jung, et al.
BMC Geriatrics|November 3, 2021
Sarcopenia is associated with decreased gray matter volume in the parietal lobe: a longitudinal cohort studyJi Hee Yu, Regina E Y Kim, Jin-Man Jung, et al.
Frontiers in Neurology|September 19, 2022
Night blood pressure variability, brain atrophy, and cognitive declineJi Hee Yu, Regina E Y Kim, So Young Park, et al.
Scientific Reports|May 28, 2024
A multimodal machine learning model for predicting dementia conversion in Alzheimer's diseaseMin-Woo Lee, Hye Weon Kim, Yeong Sim Choe, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 25, 2025
Neuroimaging correlates and biomarker performance of a fully automated plasma p-tau217/Aβ42 ratio assay in a clinical cohort with Alzheimer's diseaseYoo Hyun Um, Paul Wynveen, Mark Holland, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|November 29, 2011
Prognostic factors for idiopathic pulmonary fibrosis: clinical, physiologic, pathologic, and molecular aspectsS H Lee, H S Shim, S H Cho, et al.
Cell Death & Disease|March 15, 2014
Stronger proteasomal inhibition and higher CHOP induction are responsible for more effective induction of paraptosis by dimethoxycurcumin than curcuminM J Yoon, Y J Kang, J A Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2017
Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinomaH R Kim, H N Kang, H S Shim, et al.
Pageof 17